Aurobindo Pharma says Rs 450-crore deal to acquire 51% in Cronus Pharma cancelled


Aurobindo Pharma says Rs 450-crore deal to acquire 51% in Cronus Pharma cancelled In a regulatory filing on Friday, Aurobindo Pharma said, #39;The board of directors in its meeting held today has approved the termination of the aforesaid agreements, and the parties have mutually agreed and terminated the said agreements.#39;